HANISH ARNOLD C
SEC insider (Form 3/4/5 filer). CIK 0001233253. Director at Decoy Therapeutics Inc. (DCOY) and 1 other issuer. 12 reported Form 4/5 transactions since Sep 2024; latest on Aug 31, 2026. Located in HOUSTON, TX.
Companies HANISH ARNOLD C has filed insider reports for
- Decoy Therapeutics Inc. (DCOY): Director
- OMEROS CORP (OMER): Director
HANISH ARNOLD C
CIK: 0001233253
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (12 total)
- Aug 31, 2026DCOY
Decoy Therapeutics Inc.
AwardDirect3K shares- - Aug 27, 2026OMER
OMEROS CORP
ExerciseDirect2.5K shares at avg. $15.81$40K - Aug 27, 2026OMER
OMEROS CORP
ExerciseDirect7.5K shares at avg. $14.66$110K - Aug 27, 2026OMER
OMEROS CORP
SaleDirect5K shares at avg. $19.02$95K - Aug 27, 2026OMER
OMEROS CORP
SaleDirect5K shares at avg. $18.88$94K - Aug 26, 2026OMER
OMEROS CORP
ExerciseDirect5K shares at avg. $15.81$79K - Aug 26, 2026OMER
OMEROS CORP
SaleDirect5K shares at avg. $18.53$93K - Jun 18, 2026OMER
OMEROS CORP
AwardDirectStock Option (Right to Buy)
15K shares- - Dec 30, 2025SLRX
Salarius Pharmaceuticals, Inc.
SaleDirect12 shares at avg. $0.64$7.676 - Dec 30, 2025SLRX
Salarius Pharmaceuticals, Inc.
SaleIndirect15 shares at avg. $0.64$9.596
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 31, 2026 |  DCOY Decoy Therapeutics Inc. | Award | 3,000 | - | $0 | Direct |
| Aug 27, 2026 |  OMER OMEROS CORP | Exercise | 2,500 | $15.81 | $39,525 | Direct |
| Aug 27, 2026 | OMER OMEROS CORP | Exercise | 7,500 | $14.66 | $109,950 | Direct |
| Aug 27, 2026 | OMER OMEROS CORP | Sale | 5,000 | $19.02 | $95,081 | Direct |
| Aug 27, 2026 | OMER OMEROS CORP | Sale | 5,000 | $18.88 | $94,381 | Direct |
| Aug 26, 2026 | OMER OMEROS CORP | Exercise | 5,000 | $15.81 | $79,050 | Direct |
| Aug 26, 2026 | OMER OMEROS CORP | Sale | 5,000 | $18.53 | $92,633 | Direct |
| Jun 18, 2026 | OMER OMEROS CORP | Award Stock Option (Right to Buy) | 15,000 | - | - | Direct |
| Dec 30, 2025 |  SLRX Salarius Pharmaceuticals, Inc. | Sale | 12 | $0.64 | $8 | Direct |
| Dec 30, 2025 | SLRX Salarius Pharmaceuticals, Inc. | Sale | 15 | $0.64 | $10 | Indirect |
1-10 of 12 transactions